Silver Book Fact

Drug-resistant MRSA expensive to treat

As an example, the median treatment cost for drug-resistant MRSA patients over a 6-month period was 118% higher than the cost of treating drug-susceptible MRSA strains.

Mauldin P, Salgado C, Hansen I, Durup D, et al. Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic Resistant Gram-Negative Bacteria. Antimicrob Agents Chemother. 2009; 54(1): 109-15. http://aac.asm.org/content/54/1/109.full

Reference

Title
Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic Resistant Gram-Negative Bacteria
Publication
Antimicrob Agents Chemother
Publication Date
2009
Authors
Mauldin P, Salgado C, Hansen I, Durup D, et al.
Volume & Issue
Volume 54, Issue 1
Pages
109-15
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Hospital-acquired pneumonia leading cause of HAI
    Hospital-acquired pneumonia (HAP) is the 2nd most frequent cause of hospital-acquired infection, numbering around 300,000 cases each year.  
  • ~1.7 million Americans develop hospital-acquired HAIs annually
    Approximately 1.7 million Americans develop hospital-acquired HAIs each year.  
  • >20% of drug-resistant pneumonia in nursing homes
    More than 20% of drug-resistant cases of pneumonia in 2010 occurred in nursing home residents.  
  • ~3/4 of all HAIs occur outside of ICU
    Nearly 3/4 of all hospital-acquired HAIs occur outside of the intensive care unit (ICU).  
  • Infection and related sepsis leading cause of death in noncardiac-ICUs
    Infection and related sepsis/septicemia are the leading cause of death in noncardiac-ICUs, accounting for as many as 60% of deaths.